Publication | Closed Access
In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine)
136
Citations
20
References
2003
Year
BiochemistryFunctional SelectivityMedicinePhysiologyMechanism Of ActionReceptor (Biochemistry)Pharmacological AgentNeuropharmacologyMglu5 ReceptorPharmacotherapyNovel RadioligandPharmacologyDrug DiscoveryVivo Receptor Occupancy
| Year | Citations | |
|---|---|---|
1995 | 671 | |
1997 | 630 | |
1993 | 519 | |
2001 | 308 | |
2000 | 266 | |
2002 | 177 | |
2001 | 165 | |
2000 | 146 | |
[3H]-Methoxymethyl-MTEP and [3H]-Methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor Nicholas D. P. Cosford, Jeffrey Roppe, Lida Tehrani, Bioorganic & Medicinal Chemistry Letters BiochemistryG Protein-coupled ReceptorMedicineFunctional SelectivityMechanism Of Action | 2003 | 146 |
2002 | 144 |
Page 1
Page 1